Investing.com - Viveve Medical (NASDAQ:VIVE) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
Viveve Medical announced earnings per share of $-0.590 on revenue of $1.68M. Analysts polled by Investing.com anticipated EPS of $-0.660 on revenue of $1.68M.
Viveve Medical shares are down 53.92% from the beginning of the year, still down 76.14% from its 52 week high of $2.20 set on November 15, 2021.
Viveve Medical follows other major Healthcare sector earnings this month
Viveve Medical's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar